the helix 44 internal loop in 16S rRNA and makes base and backbone contacts that yield sequence specificity. A similar structure is formed by the aminoglycoside gentamicin C1a complexed to the decoding site oligonucleotide [ . Aminoglycosides induce miscoding by mimicking paromomycin. Distinct differences were observed in the crystal structure, particularly at A1493. Here, the the conformational change in 16S rRNA induced by a correct codon-anticodon pair.
Introduction rRNA, the helix 44 region of 16S RNA that forms the aminoglycoside binding pocket does not interact with The ribosome is the target of many clinically important antibiotics, which interfere with various steps in the any ribosomal proteins or other regions of 16S RNA [13, 14] . This illustrates why using a fragment of rRNA in translation cycle. These antibiotics often interact directly with ribosomal RNA (rRNA) in conserved regions the NMR studies discussed above recapitulated rRNA structure and function in the intact ribosome and why that are involved in ribosome function. Aminoglycoside antibiotics bind to an internal loop in helix 44 of 16S NMR was successfully used to investigate ribosomal function in this case. The crystallographic studies conrRNA, in a region called the decoding site [1, 2] . This region of the small ribosomal subunit is the site of the firmed the essential features of the model for aminoglycoside-induced miscoding discussed above. However, codon-anticodon interaction in the aminoacyl-acceptor site (A site) [3] , and aminoglycoside binding to helix 44 paromomycin in the 30S structure induces a much larger conformational change in A1492 and A1493. Similarly, causes a decrease in translational fidelity [4, 5] . Aminoglycoside binding induces a high-affinity conformation the crystal structure of a decoding site oligonucleotide in complex with two molecules of paromomycin recently of the ribosome for the codon-anticodon complex [6]; this conformation allows increased selection of incordetermined in the Westhof laboratory exhibits essentially the same features as the crystal structure of the rect tRNAs within the A site [7] .
We have explored the aminoglycoside-rRNA interaccomplex of the entire 30S subunit and the three antibiotics, including paromomycin [15] . In the decoding site tion extensively using biochemical, genetic, and strucoligonucleotide-paromomycin crystal structure, A1492 tural methods. Chemical probing and mutagenesis on and A1493 display a similar large conformational change the ribosome and a decoding site model RNA oligonuupon drug binding. cleotide confirmed the validity of the small oligonucleoHere, we recalculate the decoding site oligonucleotide model system for studying aminoglycoside interactide-paromomycin complex NMR solution structure with tion with its ribosomal target [8] . Three NMR solution a different force field in order to confirm that the force structures of the eubacterial decoding site oligonucleofield used in the original NMR structure calculation protide, free in solution and bound to the aminoglycosides tocol did not bias the original structure determined by paromomycin or gentamicin C1a, were determined [9] .
NMR. In addition, we have measured residual dipolar Paromomycin binds in the major groove of an internal couplings for the decoding site oligonucleotide-paroloop in the decoding site oligonucleotide that mimics momycin complex and recalculated the structure in order to define the global features of the solution structure nuclear Overhauser effect (NOE) crosspeaks observed in the NMR studies and demonstrate that the crystal stacks on top of the base of G1491. Ring II of the drug interacts with the major groove carbonyls of G1494 and structures do not fit all of the NOEs. The differences U1495. These two nucleotides are base paired to C1407 in the crystal and NMR structures are discussed with and U1406, respectively. Ring III projects toward the important implications for ribosome structure and lower stem from ring II and contacts the base of G1491, function.
positioning ring IV to make further backbone contacts. Ring IV forms hydrogen bonds to the backbone on both Results sides of the helix, in the lower stem at U1490 and G1491 and across the helix between G1405 and U1406.
Comparison of NMR and Crystal Structures
In Figure 1 , the lower stem residues of the RNA The section of the crystal structure of the 30S subunit (C1409-C1412 and G1488-G1491) are superimposed to bound to the three antibiotics that includes the decoding compare the crystal and NMR structures. The backbone, site-paromomycin complex is compared with the NMR particularly on the U/C1490-C1496 side of the helix, susolution structure of the decoding site oligonucleotideperimposes well. The bases of A1408, C1409, G1491, paromomycin complex in Figure 1 . The global features G1494, and U1495, as well as A/G1410 and U/C1490 of the two structures are quite similar. Paromomycin (data not shown), also superimpose well in the two strucbinds in the major groove of the RNA in the core of highly tures. The position of paromomycin, particularly rings I, conserved nucleotides that comprise the decoding site.
II, and III, superimposes well in the NMR and crystal The RNA forms a binding pocket that fits tightly around structures. Three primary differences between the NMR the drug, with many intermolecular hydrogen bonds and and crystal structures are as follows: (1) the position of electrostatic interactions. The ring I of the antibiotic inring IV of paromomycin, (2) the position of the bases of serts into a pocket in the RNA formed upon displace-U1406 and C1407 along with the backbone in the vicinity of those nucleotides, and (3) the position of the bases ment of the universally conserved A1492 and A1493 and N7 of A1493, and the N6 amino protons of A1493 form a hydrogen bond to the N1 of A1408. In the crystal structure, the two bases are much too far apart for hydrogen bonds. Since the position and orientations of G1494 and A1408 are quite similar in the two structures, only A1493 and A1492 differ between the two structures.
The published crystal structure is the entire 30S subunit with three separate drugs, including paromomycin. Although the NMR construct of the decoding site includes only 19 nucleotides from 16S rRNA, the entire binding pocket for paromomycin is within the oligonucleotide. Additionally, no other rRNA or protein density is observed in the crystal structure at or near the paromomycin binding site. However, streptomycin, a second antibiotic in the crystal structure, makes van der Waals contact and hydrogen bonds to some of the same nucleotides that paromomycin is contacting. Streptomycin increases the affinity of paromomycin for the ribosome. However, streptomycin binding does not cause the observed structural differences discussed above, as the rRNA structure observed in a decoding site oligonucleo- structures. Ring III adopts a C 2 Ј-endo conformation in paromomycin in the NMR and crystal structures is not the crystal structure, but a C 3 Ј-endo conformation in the significant, as ring IV was clearly disordered in the family NMR structure. The difference in the conformation of of low-energy NMR structures, whereas the crystal ring III is transmitted to ring IV, affecting its position. structure selects a single conformation. The difference Ring IV is in a chair conformation in both the crystal at U1406 and C1407 is also insignificant, as the overall structure and the average NMR structure, but the type helical geometry for these two nucleotides and the of chair conformation is different. In the crystal structure U1406-U1495 and C1407-G1491 base pairs is similar in the 2ٞ, 3ٞ, and 4ٞ heavy atoms are found in axial posithe two structures. U1406 and C1407 are stacked in both tions. The average NMR structure has the 2ٞ, 3ٞ, and structures. The difference is essentially in the global 4ٞ heavy atoms in equatorial positions, with the C6ٞ and bending of the structure that takes place at the assym- of ring IV in the crystal structure is not observed in The positions of A1492 and, particularly, A1493 are any member of the family of low-energy NMR solution the major difference between the crystal and NMR strucstructures. tures. In the NMR structure, the bases of A1492 and A1493 are displaced toward the minor groove upon binding to paromomycin, but they are still within the Intermolecular RNA-Paromomycin Contacts The intermolecular contacts and paromomycin-paromobinding pocket. In the crystal structure, the two bases are completely flipped out of the helix, not making conmycin contacts observed in the crystal and NMR structures of the 30S subunit and decoding site oligonucleotact to any part of the drug or any part of the 30S subunit. Additionally, it is only the bases of the two residues tide bound to paromomycin, respectively, are compared in Table 1 RNA. Since ring IV is dynamic in the NMR structure, but static in the crystal structure, NOE violations to ring IV the A1493 amino proton; in the crystal structure, the 6Ј OH hydrogen bonds to the A1408 N1. The ring II N3 to are not surprising. Protons from ring IV are transiently in close proximity to protons on the RNA, resulting in G1494 phosphate oxygen is also quite different between the crystal and NMR structures. The phosphate of G1494 observed NOEs, even though individual structures suggest that those protons are too far apart. The NOE violais positioned toward paromomycin in the crystal structure, whereas the ribose and base of A1493 occupy this tions to the two exchangeable resonances on the RNA are also not surprising, as NOEs to exchangeable prospace in the NMR structure.
tons are often hard to quantify because of the long mixing times required to observe the intermolecular NOE Violations of Crystal Structure The crystal structure of the 30S subunit-paromomycin NOEs and the solvent exchange of the proton. complex was analyzed to determine the number and magnitude of violations to proton-proton NOE distance Position of A1493 NOESY data were acquired on the decoding site oligoconstraints determined by NMR. Molecular modeling was used to build hydrogen atoms into the crystal strucnucleotide-paromomycin complex to confirm the presence or absence of an A1493-A1408 base pair on the ture. The distances between protons were then compared to the distance constraint file used for structure basis of the significant difference in the X-ray crystal structure and NMR solution structure. As shown in Table  calculation Ring IV H4ٞ 7.6 1.6 C1490 H5
Ring IV H4ٞ 7.5 2.5 C1490 H5
Ring Figure 3B shows the fields of the two programs are different, and the calcularibose region of the same NOESY spectrum in Figure  tion protocol is also different. Recalculation of the struc-3A. The NOE from the H3Ј of A1493 to the H8 of A1493 ture was carried out in order to confirm that calculation is highlighted. In the crystal structure, these two protons protocols and/or force fields are not biasing the NMRwere 2.2 Å apart, which would lead to a very intense determined structure. In addition to the use of a different NOE, one of the most intense in the spectrum, as few calculation protocol and force field, NOE-derived disprotons are that close in RNA. Although a NOE is obtance constraints were loosened relative to the original served, it is not one of the most intense in the spectrum. structure calculation to allow for any possible discrepanAlthough other factors, such as line width and relaxation, cies in the conversion of NOE volumes to proton discan affect NOE intensity, these factors alone cannot tances. A comparison of the X-PLOR recalculated strucaccount for the discrepancy. This NOE should still be tures to the crystal structure is presented in Figure 4 . the most intense for both the H3Ј and the H8 of A1493
The position for all nucleotides except A1492 and A1493 if the crystal structure conformation was predominant are within the range of low-energy recalculated strucin the decoding site oligonucleotide in solution.
tures. The position of A1492 in the recalculated structures is not as well defined as other nucleotides, and its position approaches that observed in the crystal Residual Dynamics in the Paromomycin-RNA Complex structure. The dynamics of A1492 were not noted in the original description of the NMR structure of the decodThe RNA and paromomycin moieties at the RNA-drug interface show evidence of microsecond to millisecond ing site oligonucleotide-paromomycin complex [9]. Either the difference in the forcing energies of DISCOVER exchange dynamics in the NMR structure. Resonances for the ring I 6Ј and 2Ј protons are significantly broad-3 versus X-PLOR or the tighter NMR-derived constraints in the original DISCOVER 3 calculations apparently overened, as is the A1408 H8 resonance. Broadening of these resonances is caused by conformational exconstrained the base of A1492 to a better-defined position in the original DISCOVER 3-derived structures. change processes on the microsecond to millisecond timescale; in contrast, no evidence for exchange broadHowever, even in the recalculated structures, A1493 does not approach its position in the crystal structure. ening is observed for A1492 and A1493. These qualita- 
Refining NMR Structures with Residual
The original DISCOVER 3 NMR structure of the decoding site oligonucleotide-paromomycin complex is comDipolar Couplings The structure of the decoding site oligonucleotide-paropared to the structure refined with residual dipolar couplings in Figure 6 . Globally the structures are essentially momycin complex was refined against 37 residual dipolar coupling restraints with the CNS force field [18], startthe same. Structures refined with residual dipolar couplings have a more precise bend angle between the two ing with the original DISCOVER 3 structures. The structure statistics for the refinement are presented in helical stems, since residual dipolar couplings provide long-range global restraints. The interhelical bend angle Table 3 . Of the 19 original structures, 13 converged to low energy with the additional constraints from the in the original DISCOVER 3-derived structures is 131 Ϯ 23Њ, whereas, in the residual dipolar coupling-refined residual dipolar couplings. The final refined and energyminimized structures calculated with residual dipolar structures, it is 131 Ϯ 12Њ. In the crystal structure this interhelical bend angle is 163Њ. In addition to the differcouplings are presented in Figure 5 . The overall precision of the structure is much higher with the additional ences in the interhelical bend angles, the residual dipolar coupling-refined structures are also elongated relative constraints from the residual dipolar couplings (rmsd ϭ 0.52 Ϯ 0.18 Å ). Additionally, the precision of the structure to the original NMR structures. The longest phosphate to phosphate distance in the original NMR structures in the core region interacting with paromomycin (G1405-A1410 and U1490-C1496) is much higher (rmsd ϭ 0.34 Ϯ is 32 Ϯ 4 Å . In the residual dipolar coupling-refined structures, this distance is 37 Ϯ 1 Å . The equivalent 0.16 Å ). The only nucleotide that is part of the 16S rRNA sequence that is not well defined in the new structures phosphate to phosphate distance in the crystal structure is approximately 40 Å . As expected, the residual dipolar with residual dipolar coupling restraints is A1492. The base of A1492 is dynamic in the calculated structures, coupling restraints improve the precision of the NMR structures. This is particularly true for global structural again approaching its position in the crystal structure. mycin contacts observed are similar to those observed ring I. In the crystal structure of the 30S subunit-paromomycin complex and the decoding site oligonucleotidein the entire 30S subunit-paromomycin complex, but, at the higher resolution achieved for the decoding site paromomycin complex, the 6Ј OH hydrogen bonds to the N1 of A1408, whereas, in the NMR structure, a 6Ј oligonucleotide, contacts through bound water molecules were more easily discerned from direct contacts.
OH-A1493 phosphate oxygen contact is observed. The 1408 position is an adenosine in all prokaryotic seAs in the 30S crystal structure, ring I of paromomycin displaces A1492 and A1493 toward the minor groove of quences and a guanosine in all eukaryotic cytosolic sequences [19] . Mutation of A1408 to G confers high-level the RNA in the decoding site oligonucleotide-paromomycin crystal structure. The extrusion of A1492 and resistance to all of the aminoglycosides, except those with a 6Ј OH group [20] . Structural studies in solution A1493 in this crystal structure is stabilized by intermolecular packing interactions of the two adenosines into suggested that a G1408-A1493 base pair disrupts the binding site for the drug, and a 6Ј amino group is unable the minor groove of a neighboring helix. The A site of the 30S subunit crystal structure is also in an environto hydrogen bond the phosphate backbone at A1493
[21]. Mutation of A1408 to G stabilizes the conformation ment that is rich in RNA. The NMR data are inconsistent with the presence, at 300-310 K, of a significant populaof the internal loop. As suggested by Vicens and Westhof (2001), aminoglycosides with a 6Ј OH interact with higher tion of the conformation of the decoding site observed in the crystal; the crystallographic data for both the 30S affinity to G1408 ribosomes than do aminoglycosides with a 6Ј NH 2 because the N1 imino proton can still subunit-paromomycin complex and the decoding site oligonucleotide-paromomycin complex were acquired hydrogen bond to the 6Ј OH, but not to the 6Ј NH 2 . However, the distorted binding pocket in the solution in vitreous ice at 100 K. The lower temperature would, at a minimum, dampen conformational dynamics and structure of the G1408 decoding site oligonucleotide suggests why all aminoglycoside bind to G1408 secould shift local conformational equilibria. quences with reduced affinity: the G1408-A1493 base pair disrupts the binding site for the drugs.
Biological Implications
The differences in the crystal and NMR structures are real and have implications for aminoglycoside binding All aminoglycoside antibiotics that bind to the decoding site have a hydrogen bond donor at the 6Ј position on and action on the ribosome. Aminoglcyoside binding at constraints into the force field. A total of 14 of 19 structures con-
